Atraric acid TCS1372
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of prostatic diseases. It inhibits PTP1B activity in a dose-dependent manner with IC50 values of 51.
CAS nr:
4707-47-5
Purity:
98%
Molecular Weight:
196,2
SMILES:
CC1=CC(=C(C(=C1C(=O)OC)O)C)O
Formula:
C10H12O4
Pathway:
Metabolism,Endocrinology/Hormones
Target:
Phosphatase,Androgen Receptor
